Home / Available CME / AASLD 2010 CME Newsletter

Advances in Chronic Hepatitis C Management and Treatment

AASLD-2010_eSymp_Webpage_Bannerv3.jpg 

AASLD10_Newsletter_View_Button.jpg

About the Program

Program Overview

This CME Newsletter will review and discuss the key studies on chronic hepatitis C management and treatment presented at AASLD. Contributors to this newsletter are from a distinguished faculty panel in the field of HCV, including the course director, Mark Sulkowski from the Johns Hopkins University School of Medicine.

This program is certified for CME credit for US physicians by the Postgraduate Institute for Medicine.  


Back to To

Target Audience

This activity has been designed to meet the educational needs of physicians involved in the care of patients with chronic HCV infection.

Back to Top

Learning Objectives

After completing this activity, participants should be able to:

  • Implement appropriate monitoring and testing; 

  • Explain and use, in a clinical setting, the key new studies on chronic hepatitis C management and treatment presented at the 61st AASLD;

  • Apply treatment paradigms for chronic hepatitis C;

  • Discuss with patients the studies and data on newer therapies for chronic hepatitis C presented at the 61st AASLD and use that discussion to decide on appropriate planning of therapy;

  • Apply information on newer therapies in therapeutic discussions.

 

Release Date:  November 22, 2010
Expiration Date:  November 22, 2011

Estimated time to complete the AASLD CME Newsletter: 1 hour

Media: Internet

Back to Top

Course Director and Moderator

Mark Sulkowski, MD
Associate Professor of Medicine and Medical Director,
Viral Hepatitis Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Faculty

Paul Y. Kwo, MD
Associate Professor of Medicine
Medical Director
Liver Transplantation Division of Gastroenterology and Hepatology
Indiana University School of Medicine
Indianapolis, Indiana

K. Rajender Reddy, MD
Professor of Medicine,
Professor of Medicine in Surgery,
Director of Hepatology,
Medical Director of Liver Transplantation
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania

Douglas T. Dieterich, MD,
Professor of Medicine and Director of CME,
Department of Medicine,
Director of Outpatient Hepatology,
Division of Liver Diseases,
Mount Sinai School of Medicine
New York, New York

Paul J. Pockros, MD 
Head, Division of Gastroenterology/Hepatology
Director, SC Liver Research Consortium
The Scripps Clinic
La Jolla, California

Jurgen Rockstroh, MD 
Professor
University of Bonn
Bonn, Germany

Back to Top  

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and ViralEd, LLC. PIM is accredited by the ACCME to provide continuing medical education for physicians.   

Back to Top

Credit Designation

PIM designates this educational activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Back to Top

Disclosure of Conflicts of Interest

The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Dr. Mark Sulkowski:

  • Contracted Research: Merck; Genentech/Roche; Vertex; Gilead; Boehringer Ingelheim; Tibotec

  • Consulting Fees: Merck; Genentech/Roche; Vertex; Gilead; Boehringer Ingelheim; Anadys; Tibotec; Human Genome Sciences

  • Advisory Board: Pfizer; Pharmasett

Dr. Paul Kwo:

  • Contracted Research: Merck; Vertex; BMS; Abbott; Gilead; Idenix

  • Consulting Fees: Merck; Vertex; BMS; Abbott; Gilead; Anadys

  • Speakers' Bureau: Human Genome Sciences; Merck; Roche; BMS; Gilead; GlaxoSmithKline

Dr. K. Rajender Reddy:

  • Contracted Research: Roche; Gilead; Vertex

  • Advisory Boards: Salix; Roche

  • Board Membership: American Board of Internal Medicine

Dr. Douglas Dieterich:

  • Consulting Fees: BMS; Gilead; Genentech; Boehringer Ingelheim; Merck

Dr. Paul Pockros:

  • Contracted Research: Abbott; Tibotec; Pfizer; Contus; Novartis; 3RT; Gilead; Vertex; BMS
  • Consulting Fees: Gilead; Abbott; Tibotec; Pfizer; Contus; Novartis; 3RT
  • Advisory Boards: Vertex; Merck; BMS; Tibotec; Contus; Novartis; 3RT 
  • Spakers' Bureau: Veretex; Gilead; BMS

Dr. Jurgen Rockstroh:

  • Contracted Research: Abbott; Merck; Roche
  • Conulting Fees: Abbott; BMS; Boehringer Ingelheim; Gilead; GSK; Merck; Pfizer; Roche; Tibotec; ViiV

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following planners and managers, Jan Hixon, RN, BSN, MA; Trace Hutchison, PharmD; Julia Kimball, RN, BSN; Samantha Mattiucci, PharmD; Jan Schultz, RN, MSN, CCMEP and Patricia Staples, MSN, NP-C, CCRN, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Back to Top

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Postgraduate Institute for Medicine (PIM), ViralEd, LLC and Merck & Co. do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ViralEd, LLC and Merck & Co. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Back to Top

Instructions for Participation and Credit   

There are no fees for participating and receiving credit for this activity. During the period, November 22, 2010 through November 22, 2011 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and evaluation form.

To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on the Submit Post-test at the bottom of the page. Your post-test will automatically be graded.

If you successfully complete the post-test (score of 70% or higher). your certificate will be made available immediately.  Click on View Certificate and print the certificate for your records.  If you received a score of 69% or less, you will receive a message notifying you that you did not pass the post-test.  You may retake the post-test until successful. 

You may complete the post-test onlin at: www.cmeuniversity.com

  • Click on "Find Post-Test/Evaluation by Course" on the navigation menu
  • Search by project ID: 7803
  • Upon successfully completing the Post-test and Evaluation form, your certificate will be made available immediately
  • Back to Top

    Disclaimer 

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

    Back to Top

    PIM_small

     Supported by an educational grant from Merck & Co., Inc.

    *This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings


    Recommend this page to a friend! Prepare to print

    Share this page:

    Get link code to this page                     


    Back to Top